MPA treatments were successful in increasing the infection success of CB.17 SCID mice, indicating that inherent immune traits varying between these different genetic backgrounds combined with lymphopenia and deficiency in IL-2/7 receptor signalling dictates early immune control ofD. immitis larvae in mice. Here, IL2 is linked to infection.